Previous close | 0.0120 |
Open | 0.0130 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0130 - 0.0130 |
52-week range | 0.0060 - 0.0620 |
Volume | |
Avg. volume | 14,691 |
Market cap | 1.74M |
Beta (5Y monthly) | -0.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1100 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Thrive Precision Health ("THRV") (formerly Thrive Global Biosafety and China New Energy Group Company (with subsidiary Thrive Testing and Biosafety Inc., "CNER" or "Company") (OTC-Pink-Alternative Reporting Pink: CNER) is pleased to announce it has entered into an agreement to acquire all of the assets of two diabetes clinics in Hawaii with the plan to expand to 20 clinics.
Thrive Precision Health ("THRV") (formerly Thrive Global Biosafety and China New Energy Group Company (with subsidiary Thrive Testing and Biosafety Inc., "CNER" or "Company") (OTC-Pink-Alternative Reporting Pink: CNER) is pleased to announce it has entered into a binding letter of intent to acquire two diabetes clinics on Arizona.